Stockreport

MIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2 [Yahoo! Finance]

MIRA Pharmaceuticals, Inc.  (MIRA) 
PDF – Ketamir-2 Is Being Developed As a Take Home Alternative to The Revolutionary Drug Spravato, Which Must be Dosed Under Medical Observation – BALTIMORE Nov. 20, 2023 [Read more]